Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database
Objective To assess the real-world effectiveness of casirivimab and imdevimab (CAS+IMD) versus no COVID-19 antibody treatment among patients diagnosed with COVID-19 in the ambulatory setting, including patients diagnosed during the Delta-dominant period prior to Omicron emergence.Design Retrospectiv...
Saved in:
| Main Authors: | Mohamed Hussein, Degang Wang, David M Weinreich, Robert J Sanchez, Wenhui Wei, Boaz Hirshberg, Vera Mastey, Jessica J Jalbert, Dana J Murdock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/12/e064953.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world effect of casirivimab and imdevimab cocktail in patients infected with SARS-CoV-2 delta and omicron variants
by: Rajas Subhash Walinjkar, et al.
Published: (2023-03-01) -
Development of a quality by design-based ultra-performance liquid chromatography method for the simultaneous estimation of casirivimab and imdevimab with greenness metrics
by: Sravanthi Gandu, et al.
Published: (2025-06-01) -
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study
by: Jing Xiao, et al.
Published: (2024-10-01) -
Development and indirect validation of a model predicting frailty in the French healthcare claims database
by: Hana Lahbib, et al.
Published: (2025-04-01) -
Cardiac arrhythmias in cancer patients using the nationwide claim‐based database in Japan
by: Takashi Kobayashi, et al.
Published: (2025-08-01)